Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Autoimmunity Reviews|September 4, 2012
Can we reduce the dosage of biologics in spondyloarthritis?Ignazio Olivieri, Salvatore D'Angelo, Angela Padula, et al.Expert Opinion on Pharmacotherapy|June 16, 2015
Pharmacological therapy of spondyloarthritisCarlo Palazzi, Salvatore D'Angelo, Michele Gilio, et al.Expert Review of Clinical Immunology|June 11, 2016
Improvements in diagnostic tools for early detection of psoriatic arthritisSalvatore D'Angelo, Carlo Palazzi, Michele Gilio, et al.Expert Opinion on Drug Safety|March 6, 2018
Safety of treatment options for spondyloarthritis: a narrative reviewSalvatore D'Angelo, Antonio Carriero, Michele Gilio, et al.Clinical and Experimental Rheumatology|April 6, 2013
High prevalence of Behçet's disease in southern ItalyIgnazio Olivieri, Pietro Leccese, Angela Padula, et al.The Journal of Rheumatology|October 16, 2021
Impact of the COVID-19 Pandemic on the Appropriateness of Diagnostic Pathways of Autoimmune Rheumatic DiseasesTeresa Carbone, Valentina Picerno, Vito Pafundi, et al.Mediators of Inflammation|July 28, 2018
New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway DysregulationAnna Santarsiero, Pietro Leccese, Paolo Convertini, et al.Journal of Molecular Neuroscience : MN|November 20, 2020
A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal StudyMaria Carmela Padula, Pietro Leccese, Nancy Lascaro, et al.The Journal of Rheumatology|February 12, 2009
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritisSalvatore D'Angelo, Gianna Angela Mennillo, Maria Stefania Cutro, et al.Clinical and Experimental Rheumatology|October 5, 2011
Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximabIgnazio Olivieri, Pietro Leccese, Salvatore D'Angelo, et al.Pageof 4